Ginkgo Bioworks designs custom microbes for customers across multiple markets. The Company builds their foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

Type
Private
HQ
Boston, US
Founded
2008
Size (employees)
162 (est)+2%
Ginkgo Bioworks was founded in 2008 and is headquartered in Boston, US
Report incorrect company information

Ginkgo Bioworks Office Locations

Ginkgo Bioworks has an office in Boston
Boston, US (HQ)
27 Drydock Ave
Show all (1)
Report incorrect company information

Ginkgo Bioworks Financials and Metrics

Summary Metrics

Ginkgo Bioworks's latest funding round in December 2017 was reported to be $275 m. In total, Ginkgo Bioworks has raised $429.1 m. Ginkgo Bioworks's latest valuation is reported to be $1.3 b.

Ginkgo Bioworks Financials

Market valuation

1.3 b
Show all financial metrics
Report incorrect company information

Ginkgo Bioworks News and Updates

Ginkgo Bioworks hauls in $275 mln Series D

Boston-based Ginkgo Bioworks, an organism company, has raised $275 million in Series D funding. The investors included Viking Global, Y Combinator's Continuity Fund, Cascade Investment and General Atlantic.
Report incorrect company information